← Health & Life Sciences investors
Investor profile · The Hype List
RA Capital Management
The Science-First Multi-Stage Health Investor
Visit websiteWhy it made the list
RA Capital combines a large dedicated healthcare platform with 2026 participation in major biotech financings.
Proof point
RA Capital participated in Circle Pharma's $92.5M Series E announced Sep. 16, 2026. RA reports $14.4B+ AUM as of Dec. 31, 2025 and invests from NewCo creation and Seed through public markets.
Sources: circlepharma.com, racap.com, racap.com
- Industry focus
- Health; Therapeutic; Diagnostics; Medical Devices; ClimateTech; IndustrialTech; Minerals; Sustainability
- Technology focus
- AI; DeepTech; Battery technologies; Machine Learning; Computational Biology
- Stage
- Pre-Seed; Seed; Series A-C; pre-IPO
- Geography
- Global
- Category
- The Hype List
Team
JM
in LinkedInJosh Resnick, MD
Partner
LP
in LinkedInLaura Stoppel, PhD
Partner
DP
in LinkedInDerek DiRocco, PhD
Partner
Is this investor a fit for you?
Assess your investment case and see which investors actually match your company.
Get Investor Ready